tor of Castle. Slowly evidence is accumulating that a hemolytic mechanism also may be operable in many instances. In 1907, Weil (3) reported extensive experiments in which extracts of normal kidneys and livers of dogs produced slight and somewhat variable hemolysis of dogs' erythrocytes in vitro, but extracts of sarcomas and carcinomas were much more potent in their destruction of red blood cells. He also noted that extracts of necrotic portions of tumors were much more hemolytic than undegenerated tissues. Dogs' kidneys were exposed extraperitoneally, their pedicles ligated, and the organs replaced in the body. The resulting necrotic kidneys were recovered subsequently and extracts from them proved to be many times more hemolytic against dogs' erythrocytes in sitro than extracts of nomal dogs' kidneys.
Recently Gross (4) demonstrated hemolytic activity when filtrates of mouse mammary carcinoma were incubated with normal mouse erythrocytes. In a later paper (5) he reported that extracts of most human mammary cancer destroyed human erythrocytes of homologous blood group when they were incubated together for 48 hours at 380 C. Carcinoma of the human stomach behaved similarly. Extracts of normal human breast, muscle, and thyroid gland produced no hemolysis under similar conditions. Ross, Crockett, and Emerson (1). 2 This work was supported in part by the Trust Fund of the Department of Internal Medicine and in part by the Medical Research and Development Board, Office of the Surgeon General, Department of the Army, under Contract No. DA-49O07-MD-485. (6) reported a hemolytic mechanism as a large part of the cause of the anemia in leukemia and malignant lymphoma.
Clinicians have observed patients with carcinoma who did not develop anemia until they were subjected to roentgen therapy. Indirect evidence (7) has accumulated that irradiation can also cause a hemolytic anemia. The erythrocyte level in both animals and man falls faster after irradiation than can be accounted for if complete inhibition of erythropoiesis had occurred. Anemia may develop coincident with reticulocytosis. The bone marrow is known to be hyperplastic in the anemia caused by radium poisoning. The excretion of bile pigment is increased after the administration of large doses of p32 or total body X irradiation (8) . In 1928, Heilmeyer (9) reported increased bile pigment excretion following local irradiation of uterin tumors in five patients.
There is little evidence to indicate the effects of direct irradiation on the red blood cell (10) . Fricke and Petersen (11) found that it required 56,000 roentgens to convert hemoglobin to methemoglobin in 50 per cent aqueous solution. The osmotic fragility of erythrocytes is not affected by 400 milliampere hours of X-rays in vitro, and 33,000 roentgens are necessary to make the membranes of red blood cells permeable to magnesium. No reports have been found of human transfusion survival studies with erythrocytes irradiated in zitro.
The purpose of the present study was to investigate the mechanism of the anemia and the erythropoietic response in patients with carcinoma, some untreated and some receiving X irradiation.
METHODS
The data in these studies were obtained by application of the method described by DeGowin, Sheets, and Hamil-ton of Ashby's technique of differential agglutination of erythrocytes (12) . The Our methods of enumerating erythrocyte and inagglutinable cells have been reported and discussed in detail previously (12, 13) .
Irradiation. Radium and X-rays were used in the treatment of the patients with carcinoma of the cervix uteri in the manner generally employed in this hospital. A 200-K.V. machine was used for X-ray therapy with a Thoraeus filter giving a beam with a half value layer of 2 mm. of copper. Six portals were employed routinely: two lateral portals, an anterior and a posterior portal, and two gluteal portals. Two hundred roentgens were given daily through each of two portals; consequently the daily dose in air was 400 roentgens. The total number of days of treatment with this dose was determined by the tumor dose desired. The daily X-ray dose in air has been indicated in the figures because it is more objective than the calculated tumor dose and it is not known whether the effect observed on an erythrocyte was due to irradiation of normal or malignant tissue. Treatments were given six days a week.
Radium was applied to the cervical canal by means of the Ernst applicator and left in place for varying lengths of time. The usual total dose of radium was 5,000 to 7,000 mg. hrs., given in one to three periods. The total dose and the interval between exposures are indicated on the charts for each patient.
Selection of patients. Patients with carcinoma of the cervix uteri were selected who were to receive irradiation and who were not losing significant amounts of blood by hemorrhage. Patients with other types of malignancy were selected because of extensive disease and absence of hemorrhage.
ANALYSIS OF DATA
The derivation and proof of the analyses employed have been presented in the preceding paper (14) . The experimental data consisted of the inagglutinable erythrocyte counts of the transfused cells and the total cell counts taken simultaneously. The erythrocyte count of the patient at any time t was computed by subtracting the inagglutinable cell count from the contemporaneous total cell count. The values for the observed inagglutinable cell counts and the patient's cell counts were plotted on Cartesian coordinates with cell counts on suitably scaled ordinates against time on the abscissa. Since fresh normal erythrocytes were transfused in all cases, it was assumed that the transfused cells had the same potential life span as those of the patient and that the observed destructive mechanism produced loss of the transfused cells at the same rate as those of the patient.
Demonstration of random loss of cells. The NoQ values of the transfused cell counts were calculated from equation 4 in the preceding report (14) : Measurement of rate of cell release. When random loss of transfused cells was demonstrated, inspection of the patient's cell counts and consideration of the results of similar experiments prompted the conclusion as to whether the transfusion study had been made during the induction phase of random destruction or whether in the steady state of random destruction (14) .
In Figure 6 in the preceding paper [14] ).
In the induction phase of random destruction the expected curve of the patient's erythrocytes, with the same assumptions as in the preceding paragraph, was computed from equation 27 (14) :
where Rind = the expected count of the patient's cells at time t, t = the time in days after random loss began, Z and Z + Z' = the areas in the graph as constructed in Figure 8 of the preceding paper (14) .
In in diameter, and irradiated through sterile brown paper with a 200-K.V. X-ray machine, using 0.2-mm. copper and 0.5-mm. aluminum filters at a distance of 30 cm. The exposure was 11.1 min-.utes, making a total dose of 1000 roentgens. After irradiation the plasma was removed and the erythrocytes were washed once in cold 0.9 per cent sodium chloride solution. The cells were resuspended in saline solution and infused into the vein of the recipient by gravity, without clinical reaction. The recipient, Nor. (Case 1), was a 41-yearold woman, belonging to group A Rh. +, who had previously been treated for thyrotoxicosis with radioiodine and was presently euthyroid.
The data from this experiment are plotted in The results of this study are plotted in Figure  1B , where it may be seen that the NoQ values of the inagglutinable cell counts form a horizontal line, indicating normal survival and no random loss of cells.
So far as we are aware, these are the only studies of transfusion survival of erythrocytes subjected to measured amounts of X-rays. No evidence was obtained to indicate that the erythrocytes had been damaged by the procedures. Admittedly the method is crude for calculating the dose of irradiation an erythrocyte receives in circulating through the tissues of a patient undergoing X-ray treatment with cervical carcinoma. It seems conservative to estimate that any one red cell would not receive more than 1,000 roentgens, and certainly not 2,000 roentgens. More extensive work on the effect of in vitro irradiation of dog erythrocytes has been reported by Swisher and Furth (15 Charts IA and 1B present control studies in which nornml fresh blood was exposed in vitro to 1,000 and 2,000 roentgens of X-rays and was then transfused to normal subjects. The transfused cells survived normally. The study in Chart 1C shows the transfused cells surviving normally until about 24 days after the beginning of X-ray therapy when random loss commenced. The erythrocyte counts of the subject decreased, but still exceeded the expected values and hence, it is concluded that the rate of cell release increased.
Irradiation of Patients with Carcinoma of the Cervix Uteri
Four women with carcinoma of the cervix uteri were transfused with fresh normal erythrocytes and then treated with X-rays and radium at various intervals after transfusion. The graph in Figure 1C contains the data from this transfusion study. The transfused erythrocytes survived normally for about 24 days. Seven days after inception of X-ray therapy random loss of the tagged cells, irrespective of their age, could 182 A be noted, and continued until the end of the study. The expected values for the subject's cell counts, assuming that the rate of cell release was normal and the subject's cells were destroyed randomly at the same rate as the transfused cells, are shown to be less than the observed cell counts. The conclusion is reached that the rate of release of erythrocytes to the circulation was greater than normal to compensate for the increased loss of cells.
The second patient had a constant level of erythrocyte counts before therapy with X rays and radium. The data from this study, presented in Figure 2A , indicate that the transfused cells survived normally until about 10 days after the beginning of X-ray therapy. Subsequently there was evidence of random loss of the donor's erythrocytes. Comparison of the expected erythrocyte counts of the subject with those observed led to the conclusion that the rate of cell release slightly exceeded the normal from the 24th to the 60th day after transfusion and thereafter there was rapid acceleration. The construction and interpretation of the charts is similar to that in Figure 1 . In 2A and 2B
the data indicate that an induction phase of random destruction occurred during X-ray therapy.
In both cases during X-ray therapy the erythrocyte counts of the subject decreased, but not at the rate to be expected with a normal cell release rate. It was concluded, therefore, that the rate of cell release was increased as a response to the accelerated destruction of cells. In chart 2C there was random destruction of transfused erythrocytes before irradiation was begun. Since the patient's mean erythrocyte count was about 4.5 millions per mm.', it was inferred that the experiment was conducted during a steady state of random destruction. The expected erythrocyte level of the patient was calculated as 0.67 million per mm.' These data indicate a rate of cell release of almost seven times the normal. The third patient had a normal erythrocyte level before therapy with X rays and radium. The graphs in Figure 2B show that random destruction of the transfused erythrocytes began about 10 days after inception of X-ray therapy. There was only a slight decrease in the cell counts of the subject although the expected values, computed for normal rate of cell release and loss at the same rate as the transfused cells, dropped precipitously. This calculation is based on the assumption that the random loss of cells was caused by the X-rays, but the period of observation before therapy was too brief and the random loss of transfused cells could be attributed to a hemolytic mechanism acting in a patient in a steady state of random destruction.
The fourth patient, likewise, exhibited consistently normal erythrocyte counts before therapy was begun. The data, graphed in Figure 2C , show that random destruction of transfused cells began before the inception of X-ray therapy. Therefore, it was assumed that the patient was in a steady state of random destruction and her expected erythrocyte level was computed on that hypothesis. Comparison of the observed cell level with that expected leads to the conclusion that the rate of cell release was about seven times the normal.
SPONTANEOUS HEMOLYSIS IN MALIGNANCIES
The finding of random destruction of normal erythrocytes before X-ray therapy in the patient represented in Figure 2C prompted study of patients with other forms of malignancy not subjected to irradiation. The total mass of malignant tissue in the patients with carcinoma of the cervix uteri was estimated to be small as compared with the patients selected for this phase of the study with widespread metastases and anemia.
Carcinoma of the breast. A patient with this condition was studied in whom there was widespread metastases and a slight anemia. The data for the two study periods are graphed in Figures 3A and 3B . In both there was rapid random loss of the transfused erythrocytes at substantially similar rates. Since the subject's erythrocyte counts remained constant, it was assumed that she was in a steady state of random destruction. Computation of the expected erythrocyte levels of the patient, on the assumption that her cells were being destroyed at the same rate as the normal erythrocytes, led to the conclusion that the rate of cell release was four to six times the normal.
Adenocarcinoma of the rectum. One example of this disorder was the subject of study. The charts are constructed and interpreted as in the preceding figures. The conditions of the experiments were such that all patients were considered in the steady state of random destruction. In all there was malignant disease extensively involving the bone marrow. In charts 3A and 3B are the data of two successive transfusions of biologically tagged cells from different donors to the same subject with carcinoma of the breast and bony metastases. The expected levels of the subject's cell counts were calculatd as 0.60 and 0.95 million per mm.', whereas the observed cell counts were about 4.0 and 4.3 millions. These imply cell production rates of 6.6 and 4.5 times the normal.
The patient represented in chart 3C had carcinoma of the rectum with metastasis to bone. The transfused cells underwent random loss. The expected erythrocyte level of the subject was estimated to be 1.18 The data for the short study are graphed in Figure  3C . They show that random destruction of transfused erythrocytes was present from the beginning of the study and the percentage rate continued constant until the end. The erythrocyte counts of the patient diminished, but did not reach a sufficiently low level to coincide with the expected values, until just before death. Previously the rate of cell release was faster than normal.
Multiple myeloma. Three transfusion studies were made on two patients with this disorder. The study in the first patient was continued until death.
Case 9 (Ulr.), group AB Rh.-negative, a woman of 61 years, had had backache and weight loss for six months.
Bence-Jones protein was found in the urine. The blood findings were: hemoglobin, 12 Gm. per 100 ml.; erythrocytes, 4.39 millions per mm.'; leukocytes 8,000 per mm.' with normal proportions of cells. The serum protein concentrations were normal. Initially the blood urea nitrogen and creatinine were normal but, as the study progressed, maxima of 55 mg. of blood urea nitrogen per 100 ml. and creatinine of 3.0 mg. were attained. The values for calcium, phosphorus, and phosphatase of the blood were normal. Sternal puncture revealed many typical myeloma cells. X-ray films of the bones revealed numerous osteolytic lesions in the skull, thorax, lumbar spine, and pelvis, with collapse of the second lumbar vertebra. The treatment was symptomatic.
Normal group 0 Rh.-negative blood was collected in ACD solution, stored for four hours at 4°C., centrifuged, the plasma removed, and the erythrocytes washed once in cold 0.9 per cent sodium chloride solution. A saline suspension of cells of 308 ml. was transfused in 17 minutes without reaction. The direct Coombs' test on her erythrocytes was negative. The indirect Coombs' test, using her serum and the erythrocytes of the donor, was likewise negative.
Death occurred on the 78th day after transfusion. Necropsy showed extensive distribution of myeloma cells in the skeletal system. There was hyperplasia of the erythroid elements and a relative decrease of the myeloid tissue in the bone marrow. The liver and spleen were normal.
The data are graphed in Figure 3D . During the entire study there was random destruction of the transfused normal cells. With such a rate of cell loss the expected erythrocyte counts of the patients did not correspond with the observed values until the latter had dropped from approximately 4.4 millions per mm.3 to 2.2 millions just before death. It is estimated that at the beginning of the study the rate of cell release was approximately twice the normal. The decrease of the cell counts of the patient to the expected level just before death is similar to the finding in the patient represented in Figure 3C .
A second patient with multiple myeloma was the subject of two transfusion experiments. minutes. Before the second transfusion the direct and midirect Coombs' tests were negative. The patient was transfused with 500 ml. of blood of homologous group and type on the 53rd, 60th, 65th, 72nd, 73rd, and 81st days of the first study; she received no transfusions during the second study.
At necropsy infiltrations of plasma cells were found in the bone marrow and in the submucosa and muscularis of the esophagus. The bone marrow was pale and oily and was composed primarily of myeloma cells. The spleen weighed 250 Gm. and was normal, except for an increased amount of hemosiderin in the phagocytes. There were centers of hematopoieses with myeloid elements, normoblasts, and nucleated red cells. The liver was normal, except for the presence of hemosiderin in the hepatic cells.
The data from both transfusion studies are presented in Figures 3E and 3F 
DISCUSSION
In four women with relatively localized carcinoma of the cervix uteri, the erythrocyte level was approximately normal before they were subjected to irradiation in the pelvic region. From the data obtained by transfusion of normal erythrocytes, it could be deduced that three of the four were in a normal steady state of erythrocyte production and loss by aging, whereas in the fourth the normal erythrocyte level was apparently maintained by an accelerated rate of erythrocyte release, despite rather rapid loss of cells by random destruction. In the three subjects with no initial random loss of cells, random destruction of the transfused erythrocytes occurred after irradiation with X rays for 7 to 10 days. Since in vitro irradiation of normal erythrocytes showed normal survival in normal recipients, it is inferred that the action of X rays was to initiate some hemolytic mechanism, either in normal tissue of the patient or in the carcinoma cells. These experiments cannot differentiate between the effects on normal tissue and carcinoma because no patients could be found for study who received comparable doses of radiation without having malignancy. Our methods of analysis show that despite the fact that the erythrocyte levels of the patients diminished during X-ray therapy, the rate of cell release actually increased to compensate partially for the increased loss of red cells. There may have been local depression of erythropoiesis from irradiation, but apparently, adequate erythrogenic tissue was unaffected so that partial compensatory acceleration of cell release was possible.
In four patients, selected for study because of extensive involvement of the bone marrow by malignancy (one carcinoma of the breast, one carcinoma of the rectum, two with multiple myeloma), a mechanism was demonstrated which destroyed normal transfused erythrocytes at random, and presumably acted similarly on the patients' own cells. In three of these the rate of cell release was greater than normal, maintaining a normal erythrocyte level in two and declining cell level in the third. In one patient with extreme infiltration of the bone marrow with myeloma cells, a steady state of oligocythemia was maintained by a normal rate of cell release in the face of a random destructive mechanism. The fact that the cell release rate was not accelerated could be interpreted as evidence of a degree of myelophthisic anemia, but the greatest contribution to the oligocythemia in this case was the random loss of erythrocytes.
The findings in our studies seem to be in harmony with the report of Vaughan (16) who noted an increase in the total quantity of active bone marrow and hyperplasia of the hemopoietic elements in patients with carcinomatosis and anemia. The in vitro studies of other workers (3, 4) have clearly shown that carcinomatous tissue extracts are hemolytic and furnish a possible explanation for the spontaneous random destructive mechanism observed in our studies.
SUMMARY
Fresh normal erythrocytes, irradiated in vitro with 1,000 and 2,000 roentgens, survived normally when transfused to normal recipients.
Three patients with carcinoma of the cervix uteri, with normal erythrocyte levels and normal rates of cell loss, developed a random destructive mechanism for transfused cells from 7 to 10 days after X-ray therapy was begun. They developed various grades of oligocythemia which were ascribed to excessive loss of erythrocytes from random destruction, despite actual acceleration of the rate of erythrocyte release to the circulation. A fourth patient with the same disease was demonstrated to have a spontaneous random destructive mechanism for transfused cells, but she maintained a normal erythrocyte level by accelerated rate of cell release. It is concluded that X rays act on either normal tissue or carcinoma cells to produce a hemolytic factor.
Four patients, selected for study because of extensive involvement of the bone marrow by malignant disease (one carcinoma of the breast, one carcinoma of the rectum, two with multiple myeloma), exhibited a spontaneous random destructive mechanism for transfused cells and, presumably, for their own erythrocytes. Two had normal erythrocyte levels, maintained by accelerated rate of cell release. Another had oligocythemia with an accelerated rate of cell release. A fourth maintained for many days erythrocyte counts of about 1.5 millions per mm.8 with a calculated normal rate of cell release. This patient had the most extensive infiltration of the bone marrow and the lack of acceleration of the cell release rate is the only evidence in these studies for a possible myelophthisic factor in anemia. CONCLUSIONS 1. In vitro X radiation of normal human erythrocytes with 2,000 roentgens, or less, did not affect their survival when transfused to normal recipients.
2. In vivo irradiation of normal and/or carcinomatous tissue initiated a hemolytic mechanism in patients with cancer of the cervix uteri.
3. An abnormal hemolytic mechanism occurred spontaneously in some patients with cancer.
4. The oligocythemia in eight patients with cancer was caused by hemolysis.
